Acceder

Publicaciones - ONCOLOGÍA CLÍNICA Y TRASLACIONAL

Cargando...
Encarnación J.A., Hernández A.L., López G.L., Alonso-Romero J.L., De la Fuente Muñoz M.I., Cánovas E.C., Carreño P.R., Royo-Villanova M., Manso C. Probable chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome: management with corticosteroids and intravenous immunoglobulin—a case report. Journal of Medical Case Reports. December 2025. 19. 10.1186/s13256-025-05402-z
AÑO: 2025; IF: 0.8
40676639
López-Miranda E., Pérez-García J.M., Gión M., Ribelles N., Cortez-Castedo P., Alonso-Romero J.L., García M.M., González-Santiago S., Bermejo B., Morales S., Carañana V., Garrigós L., Fernández-Pinto M., García-Vicente S., Garcia-Sanz A., Mena-Molina A., Boix O., Alcalá-López D., Llombart-Cussac A., Cortés J. Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial. Breast Cancer Research. December 2025. 27. 10.1186/s13058-025-02089-4
AÑO: 2025; IF: 5.6
40770648
Encarnacion JA, Hernandez AL, Lopez GL, Alonso-Romero JL, De la Fuente Munoz MI, Canovas EC, Carreno PR, Royo-Villanova M, Manso C. Probable chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids syndrome: management with corticosteroids and intravenous immunoglobulin-a case report. J Med Case Rep. 2025 Jul 17;19(1):351. doi: 10.1186/s13256-025-05402-z. PubMed PMID: 40676639; PubMed Central PMCID: PMC12272981.
AÑO: 2025; IF: 0.8
40676639
Encarnación J.A., Coll E., Manso C., Llorente S., Morales F., Saura I., López-Cubillana P., Martínez-Valls P.L.G., Martínez G., De la Fuente I., Cárdenas E., Alonso-Romero J.L., Ruiz P., Moya J., Domínguez-Gil B., Royo-Villanova M. Outcomes of Kidney Transplantation from Deceased Donors with Severe Acute Kidney Injury (AKIN Stage 3): A Preliminary Single-Centre Analysis. Medical Sciences. September 2025. 13. 10.3390/medsci13030188
AÑO: 2025; IF: 4.4
40981187
Boegemann M, Bennamoun M, Dourthe LM, Encarnacion JA, Hegele A, Hellmis E, Latorzeff I, Leicht W, Onate-Celdran J, Rosino-Sanchez A, Hanna K, Lencart J, Lukac M, Schioppa CA, Van Sanden S, Kramer G. Final analysis of ArtemisR, a European real-world retrospective study of apalutamide for the treatment of patients with metastatic hormone-sensitive prostate cancer. BMC Cancer. 2025 Jul 1;25(1):1119. doi: 10.1186/s12885-025-14294-7. PubMed PMID: 40597879; PubMed Central PMCID: PMC12211757.
AÑO: 2025; IF: 3.4
40597879
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

ONCOLOGÍA CLÍNICA Y TRASLACIONAL